Modeling Insights into Haemophilus influenzae Type b Disease, Transmission, and Vaccine Programs

Jackson, Michael L.; Rose, Charles E.; Cohn, Amanda; Coronado, Fatima; Clark, Thomas A.; Wenger, Jay D.; Bulkow, Lisa; Bruce, Michael G.; Messonnier, Nancy E.; Hennessy, Thomas W.

doi:10.3201/eid1801.110336

Back to Previous Page

- Add this to...
- Twitter
- Facebook
- Google Bookmarks
- LinkedIn

Modeling Insights into Haemophilus influenzae Type b Disease, Transmission, and Vaccine Programs

Published Date:

Jan 2012

Publisher's site:

http://dx.doi.org/10.3201/eid1801.110336 New Site Icon

Source:

Emerg Infect Dis. 18(1):13-20.

[PDF-443.75 KB]

Details:

Personal Authors:

Jackson, Michael L. ; Rose, Charles E. ; Cohn, Amanda ; Coronado, Fatima ; Clark, Thomas A. ; ... More ▼

Keywords:

[+]

Description:

In response to the 2007-2009 Haemophilus influenzae type b (Hib) vaccine shortage in the United States, we developed a flexible model of Hib transmission and disease for optimizing Hib vaccine programs in diverse populations and situations. The model classifies population members by age, colonization/disease status, and antibody levels, with movement across categories defined by differential equations. We implemented the model for the United States as a whole, England and Wales, and the Alaska Native population. This model accurately simulated Hib incidence in all 3 populations, including the increased incidence in England/Wales beginning in 1999 and the change in Hib incidence in Alaska Natives after switching Hib vaccines in 1996. The model suggests that a vaccine shortage requiring deferral of the booster dose could last 3 years in the United States before loss of herd immunity would result in increasing rates of invasive Hib disease in children <5 years of age.

Document Type:

Journal Article

Collection(s):

Emerging Infectious Diseases
Arctic Investigations Program

Supporting Files:

	11-0336-Techapp1_2p.pdf	application/pdf
	11-0336-Techapp2_8p.pdf	application/pdf
	11-0336-Techapp3_6p.pdf	application/pdf
	11-0336_finalR.nxml	text/plain
	license.txt	text/plain
	11-0336-F1.gif	image/gif
	11-0336-F1.jpg	image/jpeg
	11-0336-F2.gif	image/gif
	11-0336-F2.jpg	image/jpeg
	11-0336-F3.gif	image/gif
	11-0336-F3.jpg	image/jpeg
	11-0336-F4.gif	image/gif
	11-0336-F4.jpg	image/jpeg

No Related Documents.

You May Also Like:

Haemophilus influenzae Type b Disease and Vaccine Booster Dose Deferral, United States, 1998–2009

Personal Author:

Briere, Elizabeth C.; Jackson, Michael; Shah, Shetul G.; Cohn, Amanda C.; Anderson, Raydel D.; MacNeil, Jessica R.; Coronado, Fatima M.; Mayer, Leonard W.; Clark, Thomas A.; Messonnier, Nancy E.;

Published:

Aug 06 2012

Source:

Pediatrics. 130(3):414-420.

Description:

BACKGROUND : Since the introduction of effective vaccines, the incidence of invasive Haemophilus influenzae type b (Hib) disease among children <5 years of age has decreased by 99% in the United States. In response to a limited vaccine supply that be...

File Type:

[PDF - 319.97 KB]
Conjugate vaccines and the carriage of Haemophilus influenzae type b.

Personal Author:

Barbour, M. L.

Published:

1996 Jul-Sep

Source:

Emerg Infect Dis. 2(3):176-182.

Description:

Pharyngeal carriage of Haemophilus influenzae type b (Hib) is important in the transmission of Hib organisms, the pathogenesis of Hib disease, and the development of immunity to the bacterium. The remarkable success of current vaccination programs ag...

File Type:

[PDF - 37.08 KB]
Bacterial vaccines and serotype replacement: lessons from Haemophilus influenzae and prospects for Streptococcus pneumoniae.

Personal Author:

Lipsitch, M.

Published:

1999 May-Jun

Source:

Emerg Infect Dis. 5(3):336-345.

Description:

Conjugate vaccines have reduced the incidence of invasive disease caused by Haemophilus influenzae, type b (Hib), in industrialized countries and may be highly effective against Streptococcus pneumoniae. However, the serotype specificity of these vac...

File Type:

[PDF - 198.75 KB]
2017 Charles C. Shepard Science Awards : Loneliness: public health implications and potential mechanisms : June 18, 2017, 10:00 a.m.

Personal Author:

Dowling, Nicole F.; Schuchat, Anne; Cacioppo, John T.; Otten, Ron A.;

Corporate Author:

Centers for Disease Control and Prevention (U.S.); United States. Agency for Toxic Substances and Disease Registry.;

Conference Author:

Charles C. Shepard Science Awards Ceremony (2017 : Atlanta, GA)

Published:

7/7/17

Description:

Publication date from document properties. : ssa17-shepard-award-program.pdf

File Type:

[PDF - 3.79 MB]
Benefits from Immunization During the Vaccines for Children Program Era — United States, 1994–2013

Personal Author:

Whitney, Cynthia G.; Zhou, Fangjun; Singleton, James; Schuchat, Anne;

Published:

Apr 25 2014

Source:

MMWR Morb Mortal Wkly Rep. 2014; 63(16):352-355.

Description:

The Vaccines for Children (VFC) program was created by the Omnibus Budget Reconciliation Act of 1993 and first implemented in 1994. VFC was designed to ensure that eligible children do not contract vaccine-preventable diseases because of inability to...

File Type:

[PDF - 219.60 KB]